Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
J. venom. anim. toxins ; 8(2): 316-323, 2002. ilus, graf
Article in English | LILACS | ID: lil-314699

ABSTRACT

In 1919, Houssay and Negrete reported that venoms of Theraphosidae spiders induced neuromuscular blockade. In 1993, a purified toxin from Grammostola spider venom was found to block the P-type voltage-dependent calcium channel (VDCC), causing neuromuscular blockade. We studied the mode of action of Theraphosa blondii venom, a large Theraphosidae spider from Northern Brazil, Venezuela, and The Guyanas in mouse phrenic nerve-diaphragm preparation. This venom elicited a partially reversible neuromuscular blockade and did not depress directly evoked twitches or alter the membrane potential. Neostigmine produced only a poor antagonistic effect on partially blocked diaphragms. However, completely blocked miniature endplate potentials (m.e.p.ps) were reverted by neostigmine. These results can be explained by the presence of toxins in the venom that interact with the endplate receptor at the acetylcholine sites (curareminetic toxins) and toxins that inhibit the P-type voltage-dependent calcium channel (VDCC) (ômega-toxins). This study shows that Theraphosidae venoms, especially those of the Theraphosa blondii, are a source of curaremimetic toxins and ômega-toxins of possible interest as tools in bioscientific research.


Subject(s)
Animals , Rats , Neuromuscular Blocking Agents , Spider Venoms , Neostigmine
SELECTION OF CITATIONS
SEARCH DETAIL